Liquidia Corporation (LQDA)
NASDAQ: LQDA · IEX Real-Time Price · USD
12.37
-0.18 (-1.43%)
At close: Apr 25, 2024, 4:00 PM
12.53
+0.16 (1.29%)
After-hours: Apr 25, 2024, 6:42 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $940.46 million as of April 25, 2024. Its market cap has increased by 108.30% in one year.
Market Cap
940.46M
Enterprise Value
906.32M
1-Year Change
108.30%
Ranking
Category
Stock Price
$12.37
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.80M to $940.46M, an increase of 460.47%. That is a compound annual growth rate of 34.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 954.10M | -3.10% |
Apr 23, 2024 | 984.60M | -1.74% |
Apr 22, 2024 | 1.00B | -0.83% |
Apr 19, 2024 | 1.01B | -3.76% |
Apr 18, 2024 | 1.05B | -0.36% |
Apr 17, 2024 | 1.05B | 2.05% |
Apr 16, 2024 | 1.03B | -0.73% |
Apr 15, 2024 | 1.04B | -1.93% |
Apr 12, 2024 | 1.06B | -9.00% |
Apr 11, 2024 | 1.17B | 3.37% |
Apr 10, 2024 | 1.13B | -0.87% |
Apr 9, 2024 | 1.14B | -1.12% |
Apr 8, 2024 | 1.15B | -3.69% |
Apr 5, 2024 | 1.19B | 2.68% |
Apr 4, 2024 | 1.16B | -0.33% |
Apr 3, 2024 | 1.17B | -0.20% |
Apr 2, 2024 | 1.17B | 3.09% |
Apr 1, 2024 | 1.13B | 1.15% |
Mar 28, 2024 | 1.12B | -2.12% |
Mar 27, 2024 | 1.15B | -5.35% |
Mar 26, 2024 | 1.21B | 1.59% |
Mar 25, 2024 | 1.19B | -6.33% |
Mar 22, 2024 | 1.27B | 3.01% |
Mar 21, 2024 | 1.23B | 2.14% |
Mar 20, 2024 | 1.21B | -0.78% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Perspective Therapeutics | 991.89M |
Alignment Healthcare | 987.60M |
MacroGenics | 973.86M |
Bicycle Therapeutics | 961.93M |
Innoviva | 958.53M |
Cronos Group | 945.62M |
MiMedx Group | 944.94M |
Centessa Pharmaceuticals | 934.41M |